|
SCAND3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.28299951060751E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.75379974168777E-10 |
| Normal-vs-Stage2 |
2.769800E-04 |
| Normal-vs-Stage3 |
2.58180032908228E-10 |
| Normal-vs-Stage4 |
2.08066897045001E-12 |
| Stage1-vs-Stage2 |
2.584800E-03 |
| Stage1-vs-Stage3 |
3.559800E-01 |
| Stage1-vs-Stage4 |
5.834400E-04 |
| Stage2-vs-Stage3 |
2.443500E-03 |
| Stage2-vs-Stage4 |
1.65473999999E-05 |
| Stage3-vs-Stage4 |
3.671600E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.3307003256009E-10 |
| Normal-vs-AfricanAmerican |
9.68209999951952E-07 |
| Normal-vs-Asian |
1.74349978898647E-10 |
| Caucasian-vs-AfricanAmerican |
8.805200E-01 |
| Caucasian-vs-Asian |
2.479200E-01 |
| AfricanAmerican-vs-Asian |
3.873800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.63579952203474E-10 |
| Normal-vs-Female |
6.5565997076078E-10 |
| Male-vs-Female |
5.561600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.25710006240831E-10 |
| Normal-vs-Age(41-60Yrs) |
1.21480003834051E-09 |
| Normal-vs-Age(61-80Yrs) |
3.96169996808027E-09 |
| Normal-vs-Age(81-100Yrs) |
1.140000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.664400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.849800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.067800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.422800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.110000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.247600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.055900E-02 |
| Classical-VS-Follicular |
1.502840E-01 |
| Classical-VS-Other |
7.141400E-01 |
| Classical-VS-Normal |
1.38379996350579E-09 |
| Tall-VS-Follicular |
4.958100E-03 |
| Tall-VS-Other |
4.044600E-01 |
| Tall-VS-Normal |
4.38700187288532E-11 |
| Follicular-VS-Other |
9.382000E-01 |
| Follicular-VS-Normal |
1.45010000007773E-07 |
| Other-VS-Normal |
3.331600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.85530000251788E-08 |
| Normal-vs-N1 |
2.90929502710924E-11 |
| N0-vs-N1 |
5.763700E-03 |
|
|
